Breaking News

You are here » Indian-Commodity  :  Corporate  :  Dr. Reddy's Lab launches Neostigmine Methylsulfate Injection in US

14-Sep2018

Dr. Reddy's Lab launches Neostigmine Methylsulfate Injection in US

Dr. Reddy's Laboratories has launched Neostigmine Methylsulfate Injection, USP, a therapeutic equivalent generic version of Bloxiverz (Neostigmine Methylsulfate) Injection in the US market, approved by the US Food and Drug Administration (USFDA).

The Bloxiverz brand and generic had US sales of approximately $111 million MAT for the most recent twelve months ending in July 2018 according to IMS Health. Dr. Reddy's Neostigmine Methylsulfate Injection, USP is available in 5 mg/10 ml and 10 mg/10 ml multi-dose vials.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Related News

View all news

Sun Pharma reports consolidated net loss of Rs 219 crore in Q2

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2018.The company has reported net loss of Rs 906.42 crore for the quarter under review, as against net profit of......

Allahabad Bank planning to raise additional Rs 1,800-1,900 crore

Allahabad Bank is planning to raise additional Rs 1,800-1,900 crore to shore up capital adequacy. The Bank is exploring all options - government help, QIP, and hiving off non-core assets and stake in JVs.Allahabad......

RITES to acquire 33% stake in IRSDC

RITES has received in principle approval to acquire stake of 33% Equity Shares in Indian Railway Station Development Corporation (IRSDC). The Board of Directors of the company at their meeting held on......

Top News

View all news

RITES to acquire 33% stake in IRSDC

RITES has received in principle approval to acquire stake of 33% Equity Shares in Indian Railway Station Development Corporation (IRSDC). The Board of Directors of the company at their meeting held on......

Govt in favour of alignment of capital adequacy norms with Basel III norms

Instead of present stricter guidelines which restrict the lending capacity of lenders, the government is of the view that the Reserve Bank of India (RBI) should resort to Basel III norms for capital adequacy......

Infosys, Ashok Leyland and Reliance Infrastructure to see some action today

Infosys will open its next Technology and Innovation Hub in the State of Texas and hire 500 American workers in the state by 2020. The Hub will be located in Richardson, Texas and have a special focus......